Teucrium

Teucrium has delayed its inverse XRP ETF for the 19th time, pushing the earliest possible launch to October 11, 2026, a move that reflects broader uncertainty around leveraged crypto derivatives even as institutional demand for directional XRP positions has surged. The repeated postponements raise questions about regulatory risk, market readiness, or internal strategy for a product designed to profit when XRP falls.

• Teucrium has filed 19 consecutive monthly delays since April 2025, when its bullish 2x long XRP ETF began trading on NYSE
• XRP fell 62% from its July 2025 peak of $3.65 to near $1.37, the exact scenario the short ETF was built to capitalize on
• Long XRP ETFs have pulled in $1.70 billion cumulatively since launch, but no listed inverse product exists to capture bearish positioning

• 19 Consecutive monthly delays since initial April 2025 filing date
• $1.70B Cumulative inflows to long XRP ETFs since their April 2025 launch
• 62% XRP price decline from July 2025 peak to current trading level

Teucrium’s short XRP ETF has become a study in perpetual delay. According to reporting from BeInCrypto, a filing dated September 11 moved the earliest possible trading date to October 11, 2026, the 20th deadline since the fund was first announced. The filing carries no explanation beyond the new date; strategy, fees, and risk disclosures remain unchanged across all 19 postponements.

Long XRP ETF launched while short version sat idle through 62% price decline

The timeline exposes a stark asymmetry in product execution. Teucrium’s 2x long XRP ETF, designed to amplify gains when XRP rises, began trading on the NYSE in April 2025. The company then shelved the inverse version, which would pay investors when XRP falls and use daily settlement contracts rather than hold XRP directly, and has declined to launch it ever since.

What makes the delay conspicuous is that the market condition the short ETF was built for arrived and passed without it. XRP peaked at $3.65 in July 2025, just months after the long fund launched. It has since fallen to near $1.37, a 62% drawdown that would have generated substantial returns for an inverse leveraged product.

Institutional investors seeking a listed way to express bearish XRP positioning during that entire slide had no options.

Teucrium did not block these delays through regulatory channels; the company filed each postponement of its own accord.

$1.70 billion flowed into long XRP ETFs despite repeated volatility

While the short product gathered dust, long XRP ETFs attracted steady capital. Since their April 2025 launch, these funds have accumulated $1.70 billion in cumulative inflows. Over the most recent 20 trading days, they took in $190.5 million, with net withdrawals on only a single day, evidence that institutional buyers maintained conviction through the 62% decline.

The resilience of inflows into instruments betting on XRP strength contrasts sharply with the absence of any listed vehicle for the opposite bet. Institutional portfolios often require both long and short exposures for hedging or directional rotation. The missing short ETF has left that positioning entirely to over-the-counter derivatives or cash positions in XRP itself.

October 11 deadline arrives as 20th test of Teucrium’s follow-through

October 11, 2026, now stands as the earliest date the fund may commence trading. The distinction matters: approval to launch is not the same as an actual launch. Teucrium has maintained the regulatory capacity to begin operations at each prior deadline but has chosen not to.

The pattern raises a sharper question than any single delay: if Teucrium activates the short ETF on or after October 11, it will reveal whether the company was managing risk perception, awaiting market conditions, or responding to internal or external pressure. If the fund fails to launch again, institutional investors will need to assess whether a 20th postponement signals permanent shelving by another name, or whether further regulatory or market shifts remain contingent on launch.